← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Medical Officer Konstantinos Xynos sold $78K of Replimune Group, Inc.

Sold$78,112
$10.78Price
7,246Shares
−6%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, Nov 18. Filed Wed, Nov 20, 9:31 PM ET, after the close. Not investment advice.